Grace Therapeutics, Inc. Effect Of Exchange Rate Changes On Cash And Cash Equivalents
Grace Therapeutics, Inc. (GRCE) reported Effect Of Exchange Rate Changes On Cash And Cash Equivalents of CAD 48.00 thousand for the 12-month period ending 2019-03-31, per its 20-F filed 2019-06-26.
Discontinued › Cash Flow › Change in Cash
ifrs-full:EffectOfExchangeRateChangesOnCashAndCashEquivalents · last filed 2019-06-26
| Period end | Effect Of Exchange Rate Changes On Cash And Cash Equivalents 1 month | Effect Of Exchange Rate Changes On Cash And Cash Equivalents 12 month | Effect Of Exchange Rate Changes On Cash And Cash Equivalents 13 month |
|---|---|---|---|
| 2019-03-31 | 48.00K CAD 20-F · filed 2019-06-26 | ||
| 2018-03-31 | -25.00K CAD 20-F · filed 2019-06-26 | ||
| 2017-03-31 | 9.00K CAD 20-F · filed 2019-06-26 | -49.00K CAD 20-F · filed 2019-06-26 | |
| 2017-02-28 | -58.00K CAD 20-F · filed 2019-06-26 | ||
| 2016-02-29 | 64.00K CAD 20-F · filed 2018-06-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |